Somers JM, Goldner EM, Waraich P, Hsu L: Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry. 2006, 51: 100-113.
Strine TW, Chapman DP: Associations of frequent sleep insufficiency with health-related quality of life and health behaviors. Sleep Med. 2005, 6: 23-27.
Rosenberg RP: Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Ann Clin Psychiatry. 2006, 18: 49-56.
Cascade E, Kalali AH, Kennedy SH: Real-world data on SSRI antidepressant side effects. Psychiatry (Edgmont). 2009, 6: 16-18.
O'brien CP: Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005, 66 (Suppl 2): 28-33.
Dawson DA, Grant BF, Ruan WJ: The association between stress and drinking: modifying effects of gender and vulnerability. Alcohol Alcohol. 2005, 40: 453-460.
Lakhan SE, Vieira KF: Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutr J. 2010, 9: 42-
Meeks TW, Wetherell JL, Irwin MR, Redwine LS, Jeste DV: Complementary and alternative treatments for late-life depression, anxiety, and sleep disturbance: a review of randomized controlled trials. J Clin Psychiatry. 2007, 68: 1461-1471.
Heel GmbH: Neurexan Package Insert. 2004, Heel GmbH, Baden-Baden,Germany
Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M: Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with Oxazepam. J Clin Pharm Ther. 2001, 26: 363-367.
Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M: Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 2008, 106: 1728-1732.
Bourin M, Bougerol T, Guitton B, Broutin E: A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol. 1997, 11: 127-132.
Connor J, Connor T, Marshall PB, Reid A, Turnbull MJ: The pharmacology of Avena sativa. J Pharm Pharmacol. 1975, 27: 92-98.
Ruiz-Vega G, Perez-Ordaz L, Cortes-Galvan L, Juarez G: A kinetic approach to caffeine-Coffea cruda interaction. Homeopathy. 2003, 92: 19-29.
Kröz M, Anders S, Brauer D, Zerm R, Schad F, Girke M: Valerianate of Zinc in Restless Legs Syndrome: A Retrospective Analysis [in German]. Erfahrungsheilkunde. 2009, 58: 121-129.
Waldschutz R, Klein P: The homeopathic preparation Neurexan vs. valerian for the treatment of insomnia: an observational study. ScientificWorldJournal. 2008, 8: 411-420.
Hubner R, Klein P, van HR: Effectiveness of the homeopathic preparation Neurexan compared with that of commonly used valerian-based preparations for the treatment of nervousness/restlessness - an observational study. ScientificWorldJournal. 2009, 9: 733-745.
Leiser SC, Dunlop J, Bowlby MR, Devilbiss DM: Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochem Pharmacol. 2011, 81: 1408-1421.
Kuhlmann J, Wensing G: The applications of biomarkers in early clinical drug development to improve decision-making processes. Curr Clin Pharmacol. 2006, 1: 185-191.
Dimpfel W: Pharmacological modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat (Tele-Stereo-EEG). Eur Neuropsychopharmacol. 2005, 15: 673-682.
Dimpfel W, Spuler M, Koch R, Schatton W: Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology. 1987, 18: 212-218.
Dimpfel W, Schober F: Norepinephrine, EEG theta waves and sedation in the rat. Brain Pharmacology. 2001, 1: 89-97.
Sebban C, Zhang XQ, Tesolin-Decros B, Millan MJ, Spedding M: Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol. 1999, 128: 1045-1054.
Dimpfel W: Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG). Eur J Med Res. 2003, 8: 199-207.
Council of Europe, European Pharmacopoeia Commission European Directorate for the Quality of Medicines & Healthcare: European Pharmacopoeia. 2010, Council of Europe, Strasbourg
Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J. 2008, 22: 659-661.
Paxinos G, Watson C: The rat brain in stereotactic coordinates. 1982, Academic Press, New York
Dimpfel W, Spuler M, Nickel B: Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology. 1986, 16: 163-168.
Dimpfel W, Koch K, Weiss G: Early effect of NEURAPAS(R) balance on current source density (CSD) of human EEG. BMC Psychiatry. 2011, 11: 123-
Baghdoyan HA, Monaco AP, Rodrigo-Angulo ML, Assens F, McCarley RW, Hobson JA: Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J Pharmacol Exp Ther. 1984, 231: 173-180.
Bourgin P, Escourrou P, Gaultier C, Adrien J: Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport. 1995, 6: 532-536.
Shiromani PJ, Fishbein W: Continuous pontine cholinergic microinfusion via mini-pump induces sustained alterations in rapid eye movement (REM) sleep. Pharmacol Biochem Behav. 1986, 25: 1253-1261.
Dimpfel W: Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram. Neuropsychobiology. 2008, 58: 178-186.
Leathwood PD, Chauffard F, Heck E, Munoz-Box R: Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav. 1982, 17: 65-71.
Leathwood PD, Chauffard F: Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med. 1985, 2: 144-148.
Dorn M: Efficacy and tolerability of Baldrian versus Oxazepam in non-organic and non-psychiatric insomniacs: a randomized, double-blind, clinical, comparative study [in German]. Forsch Komplementar med Klass Naturheilkd. 2000, 7: 79-84.
Ziegler G, Ploch M, Miettinen-Baumann A, Collet W: Efficacy and tolerability of valerian extract LI 156 compared with Oxazepam in the treatment of non-organic insomnia–a randomized, double-blind, comparative clinical study. Eur J Med Res. 2002, 7: 480-486.
Vonderheid-Guth B, Todorova A, Brattström A, Dimpfel W: Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. Eur J Med Res. 2000, 5: 139-144.
Dhawan K, Kumar S, Sharma A: Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 2001, 78: 165-170.
Basta M, Chrousos GP, Vela-Bueno A, Vgontzas AN: Chronic insomnia and stress system. Sleep Med Clin. 2007, 2: 279-291.
Schulz H, Jobert M, Hübner WD: The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam. Phytomedicine. 1998, 5: 449-458.